Browse the full report Amniocentesis Needles Market – Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/amniocentesis-needles-market
Amniotic fluid surrounds the fetus and protects it during pregnancy it comprises of alpha fetoproteins and live fetal cells which provide important information regarding the fetus health. During amniocentesis amniotic fluid is collected for prenatal diagnosis to identify any genetic abnormality, fetal infection and neural tube defects occurring during pregnancy ensuring optimum health to both the developing fetus and mother. Amniocentesis needles are used in procedures such as fetal blood transfusion, amnioreduction, amnioinfusion etc.
100 to 150 mm needles are reigning the needle type segment for amniocentesis needles market. The impressive ergonomic features associated with these needles such as optimal length and availability in different gauge makes it very popular for amniotic fluid collection. Constant rise in obesity during pregnancy has resulted in significant increase in transabdominal thickness hence, needles larger than 150 mm are gaining huge demand for transabdominal amniocentesis fluid collection in such women population due to enhanced safety and requires less needle puncture.
Hospitals are spearheading the end user segment for amniocentesis needles market. The major parameters providing positive impetus to its market growth are rising public health awareness regarding prenatal diagnosis and provision of affordable healthcare facilities pertaining to obstetrics and gynecology complications. Diagnostic centers will be registering excellent market growth during the forecast period on account of availability of skilled workforce and advanced equipment utilized in prenatal diagnosis to identify any notable chromosomal abnormality and neural tube defects.
North America is the largest regional segment in the amniocentesis market representing a share of 34.7%. The chief contributing factors influencing its assertive market growth are rising popularity of prenatal diagnosis in first time pregnant women and domicile of companies pioneering in manufacturing of amniocentesis needles such as CooperSurgical, Inc., Becton Dickinson & Company, Medline Industries, Inc., Smith Groups, Plc., etc. Europe holds 31.5% market share and is placed second in the amniocentesis market regional segment on account of effective implementation of health guidelines pertaining to obstetrics and gynecology. Supportive regulatory environment provided by the European Medical Agency (EMA) further propels the amniocentesis needles market growth. Asia Pacific is accountable for 25.2% market share owing to factors such as significant rise in disposable income and developing healthcare infrastructure focusing primarily on mother and child welfare.
Medical device companies manufacturing amniocentesis needles are Becton Dickinson & Company, Biopsybell Srl, Cook Medical Incorporated, CooperSurgical, Inc., Laboratoire Ccd., Tsunami Medical S.r.l., Medline Industries, Inc., Ri.mos. S.r.l., Smiths Group, Plc. and Rocket Medical, Plc.
Key Market Movements:
- Global healthcare agencies effectively implementing health guidelines pertaining to obstetrics and gynecology
- Significant rise in the number of pregnant women opting for prenatal diagnosis
- Lucrative market opportunity for major players in developing regions to establish retail outlets for sale of amniocentesis needles
The latest market report published by Credence Research, Inc. “Global Amniocentesis Needles Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global amniocentesis needles market was valued at US$ 156.4 Mn in 2018, and is expected to reach US$ 205.8 Mn by 2027, expanding at a CAGR of 3.1% from 2019 to 2027.
Request Sample: https://www.credenceresearch.com/sample-request/59153